
The deal was signed between the Russia Direct Investment Fund (RDIF), which bankrolls the production and distribution of Sputnik V, and Italy's Adienne Srl company, the Italian-Russian Chamber of Commerce (CCIR), which facilitated the negotiations, said in a statement on Monday.
Adienne Srl is located in the northern Italian province of Monza and Brianza and is part of a major Swiss group, Adienne Pharma & Biotech. The company was the first to propose signing the strategic cooperation deal with the RDIF, and the talks continued for several months after that, CCIR said.












Comment: Note also that countries dealing with Sputnik V are allowed to produce the vaccine themselves, meanwhile those dealing in the experimental RNA technologies are suspiciously guarded: The Inanity of RNA Vaccines For COVID-19
See also: